Fort Washington Investment Advisors Inc Haemonetics Corp Transaction History

Fort Washington Investment Advisors Inc

$15.8 Billion
Q1 2025

A detailed history of Fort Washington Investment Advisors Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 517,086 shares of HAE stock, worth $29.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

517,086

Previous 274,130 88.63%

Holding current value

$29.6 Million

Previous $21.4 Million 53.52%

% of portfolio

0.21%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$59.34 - $80.05 $14.4 Million - $19.4 Million	242,956 Added 88.63%	517,086 $32.9 Million
Q4 2024 Jan 17, 2025	SELL	$71.16 - $93.38 $2.51 Million - $3.29 Million	-35,220 Reduced 11.39%	274,130 $21.4 Million
Q3 2024 Oct 25, 2024	BUY	$72.45 - $91.58 $5.77 Million - $7.3 Million	79,687 Added 34.7%	309,350 $24.9 Million
Q2 2024 Jul 30, 2024	BUY	$81.24 - $97.37 $4.14 Million - $4.96 Million	50,902 Added 28.47%	229,663 $19 Million
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $12.7 Million - $15.3 Million	178,761 New	178,761 $15.3 Million
Q2 2021 Aug 09, 2021	SELL	$51.81 - $118.56 $5.39 Million - $12.3 Million	-104,110 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$111.01 - $139.48 $2.49 Million - $3.13 Million	22,408 Added 27.43%	104,110 $11.6 Million
Q4 2020 Feb 03, 2021	SELL	$88.75 - $119.95 $1.02 Million - $1.38 Million	-11,480 Reduced 12.32%	81,702 $9.7 Million
Q3 2020 Nov 10, 2020	SELL	$75.65 - $93.58 $6.51 Million - $8.06 Million	-86,106 Reduced 48.03%	93,182 $8.13 Million
Q2 2020 Jul 31, 2020	BUY	$84.96 - $118.91 $8.58 Million - $12 Million	101,000 Added 129.01%	179,288 $16.1 Million
Q1 2020 May 06, 2020	SELL	$74.34 - $121.82 $2.07 Million - $3.39 Million	-27,800 Reduced 26.2%	78,288 $7.8 Million
Q4 2019 Feb 03, 2020	BUY	$114.37 - $129.46 $892,086 - $1.01 Million	7,800 Added 7.94%	106,088 $12.2 Million
Q3 2019 Nov 08, 2019	SELL	$117.16 - $138.52 $2.76 Million - $3.27 Million	-23,600 Reduced 19.36%	98,288 $12.4 Million
Q2 2019 Aug 12, 2019	SELL	$81.74 - $120.34 $3.51 Million - $5.17 Million	-43,000 Reduced 26.08%	121,888 $14.7 Million
Q1 2019 May 10, 2019	SELL	$83.25 - $102.12 $416,250 - $510,600	-5,000 Reduced 2.94%	164,888 $14.4 Million
Q3 2018 Nov 07, 2018	SELL	$89.96 - $114.58 $823,134 - $1.05 Million	-9,150 Reduced 5.11%	169,888 $19.5 Million
Q2 2018 Jul 27, 2018	SELL	$71.53 - $95.75 $4.01 Million - $5.36 Million	-56,000 Reduced 23.83%	179,038 $16.1 Million
Q1 2018 May 02, 2018	SELL	$60.72 - $74.41 $2.98 Million - $3.65 Million	-49,100 Reduced 17.28%	235,038 $17.2 Million
Q4 2017 Feb 12, 2018	BUY	$44.96 - $58.99 $12.8 Million - $16.8 Million	284,138	284,138 $16.5 Million

Others Institutions Holding HAE

# of Institutions

345

Shares Held

52M

Call Options Held

600K

Put Options Held

474K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.93B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Haemonetics Corp Transaction History